JPY2,708.50
1.33% yesterday
Tokyo, Feb 28, 07:15 am CET
ISIN
JP3351100007
Symbol
6869
Sector

SYSMEX Stock price

JPY2,707.00
-333.00 10.95% 1M
-87.00 3.11% 6M
-209.50 7.18% YTD
-64.67 2.33% 1Y
-333.63 10.97% 3Y
+401.20 17.40% 5Y
+607.49 28.93% 10Y
Tokyo, Closing price Fri, Feb 28 2025
-25.50 0.93%
ISIN
JP3351100007
Symbol
6869
Sector

Key metrics

Market capitalization JPY1.70t
Enterprise Value JPY1.68t
P/E (TTM) P/E ratio 29.48
EV/FCF (TTM) EV/FCF 28.41
EV/Sales (TTM) EV/Sales 3.35
P/S ratio (TTM) P/S ratio 3.40
P/B ratio (TTM) P/B ratio 3.68
Dividend yield 1.10%
Last dividend (FY25) JPY30.00
Revenue growth (TTM) Revenue growth 14.50%
Revenue (TTM) Revenue JPY501.85b
EBIT (operating result TTM) EBIT JPY90.89b
Free Cash Flow (TTM) Free Cash Flow JPY59.24b
Cash position JPY81.94b
EPS (TTM) EPS JPY92.69
P/E forward 29.34
P/S forward 3.32
EV/Sales forward 3.28
Show more

Is SYSMEX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

SYSMEX Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a SYSMEX forecast:

9x Buy
60%
6x Hold
40%

Analyst Opinions

15 Analysts have issued a SYSMEX forecast:

Buy
60%
Hold
40%

Financial data from SYSMEX

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
501,851 501,851
15% 15%
100%
- Direct Costs 232,318 232,318
13% 13%
46%
269,533 269,533
16% 16%
54%
- Selling and Administrative Expenses 109,497 109,497
19% 19%
22%
- Research and Development Expense 30,725 30,725
5% 5%
6%
129,311 129,311
19% 19%
26%
- Depreciation and Amortization 38,423 38,423
12% 12%
8%
EBIT (Operating Income) EBIT 90,888 90,888
23% 23%
18%
Net Profit 57,790 57,790
28% 28%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about SYSMEX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Head office Japan
CEO Hisashi Ietsugu
Employees 10,042
Founded 1968
Website www.sysmex.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today